Table 3 Cumulative PPV/Sensitivity/Specificity (%) for CIN3+ in the triage of hrHPV-positive women
hrHPV types | Primary type | For the new type | Cumulative types | ||||
|---|---|---|---|---|---|---|---|
PPV (%) | CIN3+/HPV+ | PPV (%) | CIN3+/HPV+ | PPV (%) | SEN (%) | SPE (%) | |
16 | 18.0 | 184/1020 | 18.0 | 184/1020 | 18.0 | 73.3 | 66.3 |
33 | 15.3 | 17/119 | 14.3 | 201/1139 | 17.6 | 80.1 | 62.2 |
31 | 8.2 | 11/127 | 8.7 | 212/1266 | 16.7 | 84.5 | 57.6 |
58 | 8.5 | 21/292 | 7.2 | 233/1558 | 15.0 | 92.8 | 46.7 |
45 | 8.8 | 1/32 | 3.1 | 234/1590 | 14.7 | 93.2 | 45.4 |
66 | 2.8 | 2/74 | 2.7 | 236/1664 | 14.2 | 94.0 | 42.5 |
52 | 6.0 | 6/270 | 2.2 | 242/1934 | 12.5 | 96.4 | 31.9 |
18 | 3.5 | 5/265 | 1.9 | 247/2199 | 11.2 | 98.4 | 21.4 |
35 | 7.1 | 1/59 | 1.7 | 248/2258 | 11.0 | 98.8 | 19.1 |
56 | 4.5 | 1/84 | 1.2 | 249/2342 | 10.6 | 99.2 | 15.7 |
51 | 1.7 | 1/131 | 0.8 | 250/2473 | 10.2 | 99.6 | 10.5 |
68 | 4.0 | 1/121 | 0.8 | 251/2594 | 9.7 | 100.0 | 5.7 |
59 | 1.0 | 0/56 | 0.0 | 251/2650 | 9.5 | 100.0 | 3.4 |
39 | 2.2 | 0/85 | 0.0 | 251/2735 | 9.2 | 100.0 | 0.0 |